RA CAPITAL MANAGEMENT, L.P. - 26 Sep 2025 SCHEDULE 13D Report for SAB Biotherapeutics, Inc. Common Stock, $0.0001 par value per share (SABS)
- Filing Manager
- RA CAPITAL MANAGEMENT, L.P.
- Reporting Manager
- RA Capital Management, L.P.
- Symbol
- SABS
- Shares outstanding
- 44,459,596 shares
- Disclosed Ownership
- 4,401,500 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13D
- Filing time
- 03 Oct 2025, 16:26:17 UTC
- Date of event
- 26 Sep 2025
- Next filing
- 11 Mar 2026
- SEC
- View on sec.gov
Reporting Managers (4)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| RA Capital Management, L.P. | 9.9% | 4,401,500 | 0 | 4,401,500 | /s/ Peter Kolchinsky | By Peter Kolchinsky, Authorized Signatory | 0001346824 |
| Peter Kolchinsky | 9.9% | 4,401,500 | 0 | 4,401,500 | /s/ Peter Kolchinsky | Peter Kolchinsky | 0001384859 |
| Rajeev Shah | 9.9% | 4,401,500 | 0 | 4,401,500 | /s/ Rajeev Shah | Rajeev Shah | 0001619841 |
| RA Capital Healthcare Fund, L.P. | 9.9% | 4,401,500 | 0 | 4,401,500 | /s/ Peter Kolchinsky | By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager | 0001315082 |